The OCT1, NTCP, OATP1A1, OATP1A2, and OATP1A4 promoted the drug uptake transporter (Kim et al., 2004), the NAFLD model was reduced, and the drug absorption was restrained. The gene discussed is SLC10A1; the disease is metabolic dysfunction-associated steatotic liver disease.